Sunphenon Epigallocatechin-Gallate (EGCg) in Relapsing-Remitting Multiple Sclerosis (SuniMS Study)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2007
Hypothesis: Sunphenon, a green tea extract containing 95% egcg, given daily as oral medication over a period of 18 months has anti-inflammatory and neuroprotective properties in patients with relapsing-remitting multiple sclerosis as assessed by magnetic resonance imaging and clinical examination (EDSS and MSFC).
Epistemonikos ID: 3e5eaf4409d4265a9150391ac439f23e734f6801
First added on: Mar 31, 2022